Opioid Abuse Deterrence: FDA Development Ideas Are Out Of This World

To stimulate new ideas for better formulations, outgoing FDA commissioner Hamburg consulted X Prize Foundation about innovation competition.

FDA is so intent on spurring innovation in abuse deterrence that it has considered organizing a competition looking for disruptive ideas.

But whether the health care market would need such an incentive is unclear. Current market conditions and FDA policy may...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Already a subscriber?